Yoxly
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
* | N/A | Early VC | |
Total Funding | - |
Recent News about Yoxly
EditYoxly is a company dedicated to simplifying, normalizing, and destigmatizing sexual health through its home STI test kits. These kits are designed to detect a range of infections including chlamydia, gonorrhoea, trichomoniasis, HIV, syphilis, hepatitis B, hepatitis C, and mycoplasma. The primary market for Yoxly includes individuals seeking a convenient and private way to manage their sexual health without the need for in-person appointments. The business operates in the healthcare and wellness sector, focusing on direct-to-consumer sales through its secure online portal. Yoxly's business model revolves around selling test kits directly to consumers, with revenue generated from each kit sold. The company ensures quick turnaround times for test results, typically delivering them within a few days, and offers free delivery and discreet packaging to maintain customer privacy.
Keywords: home STI test kits, sexual health, chlamydia, gonorrhoea, trichomoniasis, HIV, syphilis, hepatitis, mycoplasma, discreet packaging.